{
    "clinical_study": {
        "@rank": "11641", 
        "arm_group": [
            {
                "arm_group_label": "Project UPLIFT (Treatment)", 
                "arm_group_type": "Experimental", 
                "description": "Participants  randomly assigned to the  Treatment group receive the UPLIFT Intervention immediately after completing the Baseline Assessment. Participants can chose to participate in the Web- or phone-delivery of UPLIFT."
            }, 
            {
                "arm_group_label": "Project UPLIFT (TAU Waitlist Control)", 
                "arm_group_type": "Experimental", 
                "description": "Participants  randomly assigned to the Treatment-as Usual (TAU) Waitlist Control group will also receive the UPLIFT intervention. However, TAU Waitlist Control  participants will begin the Intervention 8 weeks after completing the Baseline Assessment. During the initial 8 weeks, participants in this group will continue whatever treatment they are currently undergoing to prevent or treat mild depressive symptoms. Participants can chose to participate in the Web- or phone-delivery of UPLIFT."
            }
        ], 
        "brief_summary": {
            "textblock": "Project UPLIFT, a home-based treatment for depression in people with epilepsy, was designed\n      to be delivered to groups by telephone or Web. The Project UPLIFT intervention materials\n      were demonstrated to be effective in treating depression among people with epilepsy in\n      Georgia.  This project will assess whether the materials are also effective for preventing\n      depression among people with epilepsy, and will extend the project beyond Georgia to\n      Michigan, Texas, and Washington."
        }, 
        "brief_title": "Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT", 
        "completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Epilepsy", 
            "Depressive Symptoms", 
            "Depression", 
            "Seizure Disorder"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder", 
                "Epilepsy", 
                "Seizures"
            ]
        }, 
        "detailed_description": {
            "textblock": "The  study is a pilot test of Project UPLIFT for depression prevention during which the\n      acceptability and estimates of effectiveness of the intervention, presented in the Web and\n      telephone modes, are assessed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  diagnosis of epilepsy\n\n          -  at least three months post initial diagnosis of epilepsy and either on medication or\n             permission of the physician\n\n          -  symptoms of depression, but absence of moderate-to-severe depression, (8 < CES-D <\n             27)\n\n          -  21 years of age and older\n\n          -  English speaking\n\n          -  had access to a telephone\n\n          -  mentally stable, as determined by a score of > 26 on the Telephone Mini-Mental Status\n             Exam (T-MMSE)\n\n          -  willing to participate\n\n          -  willing to complete assessments three times\n\n        Exclusion Criteria:\n\n          -  no  diagnosis of epilepsy\n\n          -  less than  3 months since diagnosis of epilepsy\n\n          -  no depressive symptom (CES-D <8)\n\n          -  severe depression (CES-D > 27)\n\n          -  suicidal ideation\n\n          -  previous participation in Project UPLIFT"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "130", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01941706", 
            "org_study_id": "IRB00026786", 
            "secondary_id": [
                "5RC1MD004563-02", 
                "09042433"
            ]
        }, 
        "intervention": {
            "arm_group_label": [
                "Project UPLIFT (Treatment)", 
                "Project UPLIFT (TAU Waitlist Control)"
            ], 
            "description": "Developed for home-based treatment of depression in people with epilepsy, Project UPLIFT is based upon Mindfulness-based Cognitive Therapy for depression. It includes 8 modules, group-delivered by either telephone or Web. Trainees and people with epilepsy co-facilitate the groups, supervised by a licensed mental health professional.The co-facilitators are trained and supervised by the Principal Investigator, a Georgia-licensed clinical psychologist and Associate Professor of Behavioral Science and of Epidemiology in public health. Activities are designed to increase knowledge about depression; monitoring, challenging, and changing thoughts; coping and relaxing; attention and mindfulness; focusing on pleasure; the importance of reinforcement, and preventing relapse.", 
            "intervention_name": "Project UPLIFT", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Epilepsy", 
            "Seizure", 
            "Cognitive Behavioral Therapy", 
            "Mindfulness", 
            "Depression", 
            "Depressive symptoms", 
            "prevention", 
            "Coping skills", 
            "Quality of life", 
            "Telehealth", 
            "Phone intervention", 
            "Internet-based intervention"
        ], 
        "lastchanged_date": "February 11, 2014", 
        "link": {
            "description": "For more information about Project UPLIFT", 
            "url": "http://www.sph.emory.edu/ManagingEpilepsyWell/UPLIFT"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30322"
                    }, 
                    "name": "Rollins School of Public Health"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48109"
                    }, 
                    "name": "University of Michigan"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "University of Texas Health Science Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98104"
                    }, 
                    "name": "University of Washington"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT", 
        "other_outcome": [
            {
                "description": "Changes are measured using the Satisfaction with Life Scale (Denier, E., et al., The satisfaction with life scale. Journal of Personality Assessment, 1985)", 
                "measure": "Changes in Satisfaction with Life", 
                "safety_issue": "No", 
                "time_frame": "Baseline (at 0 week), Interim (at 8 weeks), Follow-up (at 16 weeks)"
            }, 
            {
                "description": "The study uses  the Pittsburgh Sleep Quality Index to assess changes in sleep quality.", 
                "measure": "Changes in Sleep Quality", 
                "safety_issue": "No", 
                "time_frame": "Baseline (at 0 week), Interim (at 8 weeks), Follow-up (at 16 weeks)"
            }, 
            {
                "description": "The study uses Perraud, S., Development of the Depression Coping Self-Efficacy Scale (DCSES). Archives of Psychiatric Nursing, 2000 to assess changes in depression coping self-efficacy.", 
                "measure": "Changes in Depression Coping Self-Efficacy", 
                "safety_issue": "No", 
                "time_frame": "Baseline (at 0 week), Interim (at 8 weeks), Follow-up (at 16 weeks)"
            }, 
            {
                "description": "The study uses Neff, K.D. and R. Vonk, Self-compassion versus global self-esteem: two different ways of relating to oneself. J Pers, 2009. 77(1): p. 23-50.. to assess changes in self compassion.", 
                "measure": "Changes in Self Compassion", 
                "safety_issue": "No", 
                "time_frame": "Baseline (at 0 week), Interim (at 8 weeks), Follow-up (at 16 weeks)"
            }, 
            {
                "description": "The study uses the Centers for Disease Control's Behavioral Risk Factors Surveillance System (BRFSS) questionnaire to assess changes in physical and mental health quality of life.", 
                "measure": "Changes in Physical and Mental Health Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "Baseline (at 0 week), Interim (at 8 weeks), Follow-up (at 16 weeks)"
            }
        ], 
        "overall_official": {
            "affiliation": "Emory University", 
            "last_name": "Nancy J Thompson, MPH, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Changes in depressive symptoms are measured using the modified Beck Depression Inventory (mBDI).", 
            "measure": "Changes in Depressive Symptoms", 
            "safety_issue": "No", 
            "time_frame": "Baseline (at 0 week) , Interim (at 8 weeks),  Follow-up (at16 weeks)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01941706"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Emory University", 
            "investigator_full_name": "Nancy J Thompson, PhD", 
            "investigator_title": "Associate Professor, Behavioral Sciences and Health Education", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Changes in seizure severity measured using the Liverpool Seizure Severity.", 
                "measure": "Changes in seizure severity", 
                "safety_issue": "No", 
                "time_frame": "Baseline (0 week), Interim (at 8 weeks), Follow-up (at 16 weeks)"
            }, 
            {
                "description": "The changes are measured using an internally consistent scale assessing knowledge and skills associated with depression and mindfulness. The scale includes 18 true-false items assessing knowledge of depression based on the content of the UPLIFT modules. The scale also includes 13 Likert-scale assessing mindfulness skills based on the content of the UPLIFT modules.", 
                "measure": "Changes in Depression and Mindfulness Knowledge and Skills", 
                "safety_issue": "No", 
                "time_frame": "Baseline (at 0 week), Interim (at 8 weeks), Follow-up (at 16 weeks)"
            }, 
            {
                "description": "Changes in depressive symptoms are measured using the Beck Depression Inventory (BDI).", 
                "measure": "Changes in Depressive Symptoms", 
                "safety_issue": "No", 
                "time_frame": "baseline (at 0 week), Interim (at 8 weeks), Follow-up (at 16 weeks)"
            }, 
            {
                "description": "Changes in depressive symptoms are measured using the Patient Health Questionnaire (PHQ-9).", 
                "measure": "Changes in Depressive Symptoms", 
                "safety_issue": "No", 
                "time_frame": "baseline (at 0 week), Interim (at 8 weeks), Follow-up (at 16 weeks)"
            }, 
            {
                "description": "Changes in depressive symptoms are measured using the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E).", 
                "measure": "Changes in Depressive Symptoms", 
                "safety_issue": "No", 
                "time_frame": "baseline (at 0 week), Interim (at 8 weeks), Follow-up (at 16 weeks)"
            }, 
            {
                "description": "Change measured using self-reported number of seizures in the past 4 weeks.", 
                "measure": "Change in Seizure Activity", 
                "safety_issue": "No", 
                "time_frame": "Baseline (0 week), Interim (at 8 weeks), Follow-up (at 16 weeks)"
            }
        ], 
        "source": "Emory University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University of Michigan", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Washington", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "The University of Texas Health Science Center, Houston", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "National Center on Minority Health and Health Disparities (NCMHD)", 
                    "agency_class": "NIH"
                }
            ], 
            "lead_sponsor": {
                "agency": "Emory University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2009", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}